Klaria Pharma has a total of 170 patents globally, out of which 70 have been granted. Of these 170 patents, more than 65% patents are active. The United States of America is where Klaria Pharma has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United Kingdom seems to be the main focused R&D centre and also Sweden is the origin country of Klaria Pharma.
Klaria Pharma was founded in 2015. The company develops and sells medicines for migraines and cancer-related pain. The company uses a patented drug delivery system made from an alginate-based polymer film.
Do read about some of the most popular patents of Klaria Pharma which have been covered by us in this article and also you can find Klaria Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Klaria Pharma patent portfolio.
How many patents does Klaria Pharma have?
Klaria Pharma has a total of 170 patents globally. These patents belong to 11 unique patent families. Out of 170 patents, 111 patents are active.
How Many Patents did Klaria Pharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Klaria Pharma Applications Filed | Klaria Pharma Patents Granted |
| 2025 | – | 5 |
| 2024 | 3 | 6 |
| 2023 | 1 | 12 |
| 2022 | 8 | 4 |
| 2021 | 4 | 12 |
| 2020 | 34 | 4 |
| 2019 | 35 | 2 |
| 2018 | 37 | 13 |
| 2017 | 14 | 1 |
| 2015 | – | 2 |
How many Klaria Pharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Klaria Pharma File in Different Countries?
Countries in which Klaria Pharma Filed Patents
| Country | Patents |
| United States of America | 15 |
| Europe (EPO) | 11 |
| China | 9 |
| Israel | 8 |
| Japan | 8 |
| Australia | 8 |
| Brazil | 8 |
| Korea (South) | 8 |
| Canada | 8 |
| Mexico | 7 |
| India | 7 |
| South Africa | 7 |
| United Kingdom | 6 |
| Hong Kong (S.A.R.) | 6 |
| Russia | 5 |
| Germany | 5 |
| New Zealand | 5 |
| Austria | 4 |
| Spain | 3 |
| Poland | 2 |
| Slovakia | 2 |
| Slovenia | 2 |
| Denmark | 2 |
| Italy | 2 |
| Hungary | 2 |
| Croatia | 2 |
| Portugal | 2 |
| Norway | 2 |
| Cyprus | 1 |
| Albania | 1 |
| Estonia | 1 |
| Serbia | 1 |
| Lithuania | 1 |
| Sweden | 1 |
Where are Research Centers of Klaria Pharma Patents Located?
10 Best Klaria Pharma Patents
WO2019219773A1 is the most popular patent in the Klaria Pharma portfolio. It has received 26 citations so far from companies like Bol Pharma, GW Research Limited, Orcosa Inc.
Below is the list of 10 most cited patents of Klaria Pharma:
| Publication Number | Citation Count |
| WO2019219773A1 | 26 |
| WO2018091473A1 | 8 |
| US8759282B2 | 8 |
| WO2019224323A1 | 7 |
| US20210346277A1 | 5 |
| EP1976562B1 | 5 |
| US20220280453A1 | 4 |
| WO2021037960A1 | 4 |
| WO2021028578A1 | 4 |
| US11219600B2 | 3 |
What Percentage of Klaria Pharma US Patent Applications were Granted?
Klaria Pharma (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 57.14%.
Below are the key stats of Klaria Pharma patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Klaria Pharma?
| Law Firm | Total Applications | Success Rate |
| Hamilton Brook Smith & Reynolds PC | 11 | 66.67% |
| Harness Dickey Troy | 1 | 0% |
| Renner Otto Boisselle & Sklar Llp | 1 | 0% |
What are Klaria Pharma key innovation segments?
What Technologies are Covered by Klaria Pharma?
The chart below distributes patents filed by Klaria Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where Klaria Pharma thinks it’s important to protect particular technological inventions.
R&D Focus: How has Klaria Pharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Klaria Pharma?
